Magnus Förnvik Jonsson
1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Evaluation of a Particle Enhanced Turbidimetric Immunoassay (PETIA) for detecting calprotectin in sputum samples
- Contribution to journal › Article
-
Mark
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
- Contribution to journal › Article
- 2025
-
Mark
Comparison of CSF biomarkers in multiple sclerosis patients treated with natalizumab and rituximab
- Contribution to journal › Article
-
Mark
Concordance between the updated Elecsys cerebrospinal fluid immunoassays and amyloid positron emission tomography for Alzheimer's disease assessment : findings from the Apollo study
- Contribution to journal › Article
-
Mark
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelines
- Contribution to journal › Scientific review
-
Mark
A non-affinity-dependent high-resolution mass spectrometry method for detecting and typing monoclonal free light immunoglobulin chains
- Contribution to journal › Article
- 2022
-
Mark
Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration
- Contribution to journal › Article
- 2021
-
Mark
A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female
- Contribution to journal › Article
- 2020
-
Mark
Shrunken pore syndrome and mortality : a cohort study of patients with measured GFR and known comorbidities
- Contribution to journal › Article
-
Mark
Identification of the major rabbit and guinea pig semen coagulum proteins and description of the diversity of the REST gene locus in the mammalian clade Glires
- Contribution to journal › Article
